Speech-Language Pathologists in Bridgeville, PA Accepting Medicare

16 Speech-Language Pathologists found. Showing 1 - 16

Shanna Renee Vucinic Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 107 Knox St, Bridgeville, PA 15017 Phone: 412-715-5857

Celina Courtwright Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8724 Lindsay Ln, Bridgeville, PA 15017 Phone: 724-554-6370

Angela Caruso, M.S. CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1001 Hastings Park Dr, Bridgeville, PA 15017 Phone: 412-365-5239

Katie Lynn Cunningham Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 205 Millers Run Rd, Suite 2, Bridgeville, PA 15017 Phone: 412-692-3441

Mrs. Jamie Lynn Mizia, SLP MS-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 663 Elm St, Bridgeville, PA 15017 Phone: 412-431-3358

Molly Anne O'donnell Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3590 Washington Pike, Bridgeville, PA 15017 Phone: 215-764-7966

Miss Rachel Zoe Zuckman, MA/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3590 Washington Pike, Bridgeville, PA 15017 Phone: 412-257-2474    Fax: 412-257-4521

Megan Katherine Disher, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1370 Washington Pike Ste 500, Bridgeville, PA 15017 Phone: 412-420-2273

Shane St. Esprit, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 205 Millers Run Rd, Bridgeville, PA 15017 Phone: 412-692-3734

Scott Gilbert, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3590 Washington Pike, Bridgeville, PA 15017 Phone: 412-257-2474

Elizabeth Musial Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1370 Washington Pike, Bridgeville, PA 15017 Phone: 412-838-0212

Hannah Mae Tunney, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 Bursca Dr Ste 804, Bridgeville, PA 15017 Phone: 412-320-6757

Berry Speech Academy Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 Taylor Way Ste 1, Bridgeville, PA 15017 Phone: 937-307-8959

Miss Amanda Wildman, M.S., CF-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 205 Millers Run Rd, Bridgeville, PA 15017 Phone: 412-692-3441

Speech Therapy Specialists, Llc Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 3164 Washington Pike, Bridgeville, PA 15017 Phone: 724-630-8757    Fax: 412-319-7333

Kelly Beck Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 253 Portman Ln, Bridgeville, PA 15017 Phone: 412-221-1401

News Archive

Positive clinical data of CytRx's aldoxorubicin to be presented at ASCO 2015

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced an upcoming poster presentation regarding its lead drug candidate, aldoxorubicin, at the 2015 American Society of Clinical Oncology Annual Meeting, which is being held May 29 - June 2, 2015 in Chicago.

Advances in genomic techniques help understand cancer at cellular and molecular level

Cancer is a complex disease and only thanks to advances in genomic techniques have researchers begun to understand, at a cellular and molecular level, the mechanisms which are disrupted in cancer cells. This knowledge is a key prerequisite for developing effective treatment strategies.

Young binge drinker dies after he was refused a liver transplant

A 22 year old British man who was refused a liver transplant has died from cirrhosis of the liver after a binge-drinking habit which began when he was age 13.

LJPC completes dosing in Phase 2 clinical trial of GCS-100 for treatment of chronic kidney disease

La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the "Company" or "La Jolla"), a biotechnology company developing therapeutics targeting significant unmet, life-threatening diseases today announced that it has completed dosing of its Phase 2 clinical trial of GCS-100 for the treatment of chronic kidney disease ("CKD") and has collected the final data for evaluation of the primary endpoint.

Read more Medical News

› Verified 5 days ago